FGF2 and myocardial infarction: For instance, in one study, they enhance the CorMatrix–ECM patch with basic fibroblast growth factor (bFGF), a potent inhibitor of fibrosis, to study its effects on myocardial fibrosis, chamber dilation, and progression to heart failure in a rat MI model 16 weeks post-treatment.